|
LSM12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.358500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.162200E-03 |
| Normal-vs-Stage2 |
1.234790E-04 |
| Normal-vs-Stage3 |
2.023400E-01 |
| Normal-vs-Stage4 |
1.282420E-01 |
| Stage1-vs-Stage2 |
1.777930E-02 |
| Stage1-vs-Stage3 |
1.861580E-01 |
| Stage1-vs-Stage4 |
5.402000E-01 |
| Stage2-vs-Stage3 |
2.043400E-03 |
| Stage2-vs-Stage4 |
1.601920E-02 |
| Stage3-vs-Stage4 |
7.079800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.313660E-02 |
| Normal-vs-AfricanAmerican |
1.212240E-01 |
| Normal-vs-Asian |
1.813200E-01 |
| Caucasian-vs-AfricanAmerican |
7.027200E-01 |
| Caucasian-vs-Asian |
5.596800E-01 |
| AfricanAmerican-vs-Asian |
4.688000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.047600E-02 |
| Normal-vs-Female |
5.958400E-03 |
| Male-vs-Female |
8.754600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.611850E-02 |
| Normal-vs-Age(41-60Yrs) |
7.913700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.420300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.033990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.432800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.569000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.229600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.125700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.769800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.397600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.660200E-02 |
| Classical-VS-Follicular |
2.152400E-02 |
| Classical-VS-Other |
4.996400E-01 |
| Classical-VS-Normal |
1.762040E-02 |
| Tall-VS-Follicular |
8.002600E-03 |
| Tall-VS-Other |
8.225200E-01 |
| Tall-VS-Normal |
9.189600E-01 |
| Follicular-VS-Other |
2.178600E-01 |
| Follicular-VS-Normal |
2.187700E-04 |
| Other-VS-Normal |
7.474600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.040600E-03 |
| Normal-vs-N1 |
7.969400E-01 |
| N0-vs-N1 |
1.595440E-03 |
|
|
